This study was to evaluate whether high body mass index (BMI) or thyroid stimulating hormone (TSH) level would affect selecting thyroid nodule for fine-needle aspiration biopsy (FNA) after ultrasound (US) evaluation. Materials and Methods: A total of 3155 thyroid nodules (2159 benign and 996 malignant nodules) were included. Four grades of BMI and three levels of TSH were applied for grouping. US features of the thyroid nodules were divided into 'probably benign' and 'suspicious for malignancy' categories. Patients were grouped according to gender and univariate and multivariate logistic regression analysis were used to find the association between variables and malignancy. Results: TSH levels were significantly higher in the malignant group (p＜0.001). The grades of BMI did not show difference between the malignant and benign groups (females, p=0.074 and males, p=0.157). Younger age and 'suspicious for malignancy' US category were independent risk factors for malignancy in both genders. In females, a high TSH level (odds ratio=1.010, p＜0.001) had significant association with malignancy. Except for younger age (odds ratio=0.998, p＜0.001), no variable in nodules with 'probably benign' US category was significantly associated with malignancy. Conclusion: High TSH levels were more frequent in thyroid malignancy group, but neither high BMI nor high TSH level give additional information for FNA selection after US.
Introduction
Thyroid cancer incidence has been sharply increasing worldwide during the last few decades. 1, 2) This is partially due to increased medical surveillance and the widespread use of highly sensitive diagnostic tools such as ultrasound (US) and fine-needle aspiration biopsy (FNA).
1) However, the increased incidence of large papillary thyroid cancer cannot be explained solely by these reasons. 3) There are many potential risk factors for thyroid cancer such as ionizing radiation, history of thyroid cancer in first degree relatives, prior history of thyroid
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cancer, and a high calcitonin level. 4, 5) Recently, attention has been drawn toward obesity, which may be another potential risk factor for thyroid cancer, as there was a dramatic increase in the prevalence of both thyroid cancer and obesity during the similar period. 3, 6) Up to the present, the best level of evidence has been derived from a pooled analysis of prospective studies (n=848,932) showing that obesity is an independent risk factor for thyroid cancer (hazard ratio: 1.21 in men and 1.16 in women). 7) This was also true in a health checkup setting with 15068 subjects and with FNA results of 1427 patients; the prevalence of thyroid cancer in women was associated with a high body mass index (BMI), per 5 kg/m 2 increase (odds ratio [OR], 1.63; p＜0.001). 8) Along with high BMI, a high thyroid stimulating hormone (TSH) level was reported to be a risk factor for malignant thyroid nodules. [9] [10] [11] There was a positive association between BMI and TSH levels in a study that included euthyroid patients 12, 13) as well as hypothyroidism patients. 14) Although association between thyroid cancer and high BMI or high TSH level has been reported, risk stratification of thyroid nodules detected on US follows the US feature of nodules. Therefore, the most important factor that determines the need for FNA is US features of a thyroid nodule, not BMI or TSH level.
None of the previous studies have evaluated the association of high BMI or TSH levels with thyroid malignancy after adjusting for US features and it remains unclear whether these two potential risk factors would affect nodule selection for FNA. Therefore, the purpose of this study was to evaluate whether high BMI or TSH levels would affect the selection of thyroid nodules for FNA after US evaluation, an essential procedure for choosing an adequate treatment plan.
Materials and Methods
This retrospective study was approved by the institutional review board, and informed consent was waived. Informed consent for US-guided FNA was obtained from all patients prior to each biopsy.
Study Population
Among thyroid nodules that were biopsied in our All FNA on thyroid nodules was done under US guidance. For FNA, a 23-gauge needle attached to a 2-mL disposable plastic syringe was used. In each nodule, aspiration was done twice or more and aspirated materials were expelled onto glass slides followed by smearing. All smeared glass slides were placed in 95% alcohol for Papanicolaou staining and the remaining material was rinsed in saline solution.
After the glass slides of expelled aspirated material were moved to the pathologic department, they were interpreted by five experienced cytopathologists.
Statistical Analysis
Two sample t-tests were used to compare con- The number of nodules with each clinical and US feature is shown in Table 1 . Patients with malignant nodules were significantly younger compared to patients with benign nodules in both genders (p＜0.001). 
Discussion
In this study, malignant thyroid nodules were significantly associated with 'suspicious for malignancy' US category in both genders on multivariate analysis.
In terms of TSH and BMI, there were different results according to the gender on multivariate analysis. High TSH levels in females and low BMI grades in males were significantly associated with malignancy.
However, when we evaluated the association of thyroid malignancies according to US category, neither a BMI grade nor a TSH level was significantly associated with malignancy in nodules with the 'probably benign' US category. On the other hand, a high TSH level in females and a low BMI grade in males were significantly associated with malignancy in nodules with the 'suspicious for malignancy' US category. Therefore, neither a BMI grade nor TSH levels have additional value in the selection of thyroid nodules for FNA after adequate categorization with US. These results are important because, to date, although the significant associations between malignancy and BMI or TSH levels have been studied, [7] [8] [9] [10] there has been no study showing whether different approaches are needed for patients with BMI or TSH levels when performing FNA.
Before multivariate analysis was done to evaluate clinical factors and malignant thyroid nodules, we performed the interaction test between BMI and TSH because a high BMI and TSH level have been shown to have positive association with thyroid malignancy. 12, 13, 21) It is well known that TSH is related to the energy metabolism of the body, 22) and perhaps due to the higher prevalence of hypothyroidism in obesity, there are early studies showing increased TSH levels in patients with high BMI. 14, 23) However, in our study, there was no significant association between BMI values and TSH levels, i.e., increasing BMI values and high TSH levels did not show significant association. Therefore, it was possible to include both BMI grade and TSH level as confounding factors in multivariate analysis to evaluate their association with malignant thyroid nodules.
The association between high BMI, TSH level, and risk of thyroid cancer cannot be explained in a simple manner. One proposed mechanism is explained by the role of leptin, which is an adipokine and known to be related to obese patients. 24) Elevated leptin levels will increase susceptibility to thyroid autoimmunity, which can lead to hypothyroidism and elevated TSH levels. 25) Another main mechanism is explained by insulin resistance in obese patients. 26) Insulin resistance, which is also related to diabetes mellitus, increases the insulin level in obese patients. Insulin can promote the secretion of regulatory factors including adipocytokines and TSH. 26) In either of the suggested mechanisms, a high BMI will lead to a subsequent elevated TSH level and the increased amount of TSH stimulates the production of thyroid hormones and influences the growth and differentiation of thyroid cells. 27) The positive association between a high TSH level and increased risk of thyroid cancer 28) and its aggressiveness 29) have been revealed. Recently, therapeutic strategy for thyroid cancer by means of controlling obesity with a drug has also been studied in mouse models. 30) TSH stimulates the production of thyroid hormones and supports thyroid growth. 27) Although it is still controversial, some conclude that TSH receptor stimulation is related to the increased incidence and aggressiveness of thyroid cancer, 29) and there are reports that a high TSH level was significantly associated with thyroid malignancy. 9, 10) On the other hand, suppression of TSH prevents the growth of thyroid nodules. 31) In our study, although it was not a significant factor in determining nodules for FNA, a high TSH level was significantly associated with malignancy in both univariate and multivariate analysis.
In a previous study, a low TSH level was associated with a lower risk of thyroid malignancy. 32 36, 37) Still, other studies reported that a larger nodule is associated with higher risk of malignancy. 38, 39) The higher malignancy rate in smaller nodules in our study could be related to higher rate of FNA on smaller nodules with suspicious US feature. There were some limitations to our study. First, there is an inevitable selection bias in our study. If a patient did not undergo surgery after FNA with inconclusive cytological results (indeterminate, suspicious for papillary thyroid carcinoma, or nondiagnostic), those nodules were excluded from the study subjects. Second, there is a possibility of false-negative or false-positive results for the thyroid nodules, as we included FNA cytological results, not surgical pathology, of malignant and benign nodules. However, we cannot attribute the potential misinterpretation of the results to false results on FNA, as previous studies conducted in our institution showed a relatively low rate of false-negative (1.9-3.2%) or false-positive (1.9%) results. 16, 40) Third, there was a relatively small number of obese patients (3.23%, n=102) in our study population, which may limit the hazard assessment of the various factors.
Different results may be found in other study populations with a higher proportion of obese patients such as in western countries. Lastly, there were two different methods for TSH assay and associated two different reference levels for normal TSH level.
According to a previous study, although the two assay methods well correlate with each other, IRMA was more sensitive than radioimmunoassay. 41) In conclusion, although there were more malignant thyroid nodules in patients with a high BMI grade or high TSH level, high BMI and high TSH levels were not significant factors in the determination of thyroid nodules for FNA when considered with US features.
